LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Top News  :  Lupin's JV completes global Phase III clinical trial of Etanercept biosimilar

Lupin's JV completes global Phase III clinical trial of Etanercept biosimilar (08-Feb-2018)

Lupin's joint venture (JV) YL Biologics (YLB) has successfully completed global Phase III clinical trial of its investigational Etanercept biosimilar (YLB113). The Phase III study of YLB113 was a multinational randomized double-blind controlled trial of 52 weeks duration which included more than 500 patients with rheumatoid arthritis (RA) in 11 countries. It compared YLB113's efficacy and safety directly against Enbrel (of Amgen/Pfizer) which has a global market of $11 billion (IQVIA MAT Q3 2017), and is a widely successful biologic agent globally used for the treatment of multiple autoimmune disorders including RA. YLB is a joint venture between the company and Yoshindo in Japan.

The primary endpoint was an equivalent improvement in the rheumatoid arthritis, as measured by American College of Rheumatology 20 (ACR20) response rate. The ACR20 response rate of YLB113 has been found to be within a pre-defined equivalence margin that is expected by most advanced regulatory agencies for marketing authorization. In addition, safety and immunogenicity (antibody formation) of YLB113 was also found to be similar to Enbrel indicating therapeutic equivalence.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.


Top News Today
Autoline Industries enters into MoU with Tae Sung
(25-Apr-2018)

Autoline Industries enters into MoU with Tae SungAutoline Industries has entered into Memorandum of Understanding (MoU) with TS ENG. CO., Korea (Tae Sung) on April 19, 2018 for getting technical assistance for low cost manufacturing of stamping die,......click on news to read complete article.

Hero MotoCorp, MPS and RPP Infra to see some action today
(25-Apr-2018)

Hero MotoCorp, MPS and RPP Infra to see some action todayHero MotoCorp has made an upward revision in the ex-showroom prices of its motorcycles and scooters, with immediate effect. The upward revision in the prices has been done to partially off-set the consistently......click on news to read complete article.

Hero MotoCorp hikes prices of its products
(25-Apr-2018)

Hero MotoCorp hikes prices of its productsHero MotoCorp has made an upward revision in the ex-showroom prices of its motorcycles and scooters, with immediate effect. The upward revision in the prices has been done to partially off-set the consistently......click on news to read complete article.

International Stock News
US markets closed lower; rising bond yields spook investors
(25-Apr-2018)

US markets closed lower; rising bond yields spook investorsThe US markets closed lower on Tuesday, led by a selloff in industrials, materials and technology shares. The selling pressure came after the 10-year Treasury yield briefly touched the psychologically......click on news to read complete article.

Asian markets trade mostly in red in early deals on Tuesday
(24-Apr-2018)

Asian markets trade mostly in red in early deals on TuesdayMost of the Asian equity indices are trading lower in the early deals on Tuesday as a deluge of US government debt this week and the specter of inflation and a higher fiscal deficit drove US borrowing......click on news to read complete article.

US markets closed mostly lower; S&P reports minor gain
(24-Apr-2018)

US markets closed mostly lower; S&P reports minor gainThe US markets closed mostly lower on Monday, as investors grappled with rising bond yields and a mixed bag of earnings reports. The closely watched yield on the 10-year Treasury note climbed, settling......click on news to read complete article.

 

     
  
Recent Top News News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.